Disclosure Of Non-Current Assets Held For Sale And Discontinued Operations [Text Block]

Innate Pharma - Filing #2821023

Concept 2020-01-01 to
2020-12-31
2019-01-01 to
2019-12-31
Disclosure of non-current assets held for sale and discontinued operations [text block]
Disclosure of analysis of single amount of discontinued operations [text block]
Disclosure of analysis of single amount of discontinued operations [abstract]
Disclosure of analysis of single amount of discontinued operations [line items]
Profit (loss) before tax
63 984 EUR
20 759 EUR
Revenue
70 451 EUR
85 814 EUR
Cash flows from continuing and discontinued operations [abstract]
Cash flows from (used in) operating activities [abstract]
Cash flows from (used in) operating activities
51 767 EUR
34 924 EUR
Cash flows from (used in) investing activities [abstract]
Cash flows from (used in) investing activities
13 370 EUR
62 121 EUR
Cash flows from (used in) financing activities [abstract]
Cash flows from (used in) financing activities
1 177 EUR
77 765 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.